Company / Cash per Share
Tarsus Pharmaceuticals, Inc. Cash per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$4.79
FY2025
5-year range
$2.77 / $8.43
FY2021-FY2025
Trend
+72.8%
vs FY2024
Sector context
#43 of 205
Health Care
What the data says
Tarsus Pharmaceuticals, Inc.'s cash per share of $4.79 is higher than 79% of companies in the Health Care sector (FY2025). Cash per Share has fluctuated over the past 7 years, ranging from $2.77 in FY2024 to $27.09 in FY2020.
Based on SEC 10-K filings.
4.79 in FY2025 with a 5-year CAGR of -29.3%. Top quartile in the Health Care sector.
Declined from $8.42 to $4.79 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +11.4%
- 5-Year CAGR
- -29.3%
- 10-Year CAGR
- -
Sector benchmark
-93.4% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 72.8% year-over-year.
- Ranks #43 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2020.
- Lowest cash per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.79 | +72.8% |
| FY2024 | $2.77 | -67.1% |
| FY2023 | $8.42 | +143.4% |
| FY2022 | $3.46 | -58.9% |
| FY2021 | $8.43 | -68.9% |
| FY2020 | $27.09 | +10.4% |
| FY2019 | $24.53 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026